Introduction
In 1997, the Director of the US National Institute of Drug Abuse (NIDA) described addiction as a "chronic, relapsing brain disease." 1 The main tenet of this "brain disease model of addiction" is that addiction is more than simply a poor choice or a moral failing. Rather, it is a loss of control over behavior that is driven by neurobiological changes produced by chronic drug use that drives continued use, despite the harm that it causes. 1 NIDA has since promoted this explanation of addiction to policymakers and the public, on the basis that it will reduce the stigma of addiction, lead to the development of more efficacious treatments, and promote more compassionate policy responses to addicted individuals. 2, 3 While originally this language of addiction as a brain disease was applied to alcohol and illicit drug dependence, it is now being applied to smoking. Recently, nicotine addiction was described as a "chronic brain disorder" and a "chronic, relapsing disorder" 4, 5 that requires a "chronic disease management approach" including personalized medications and counselling. Clinical practice guidelines also describe tobacco dependence as a "chronic disease" that will require repeated intervention. 6 This reflects a shift from encouraging and supporting smokers to quit, to providing repeated medical treatment and monitoring.
The idea that nicotine addiction is a medical condition is not new. The work of Michael Russell in the 1980s was central to the recognition of nicotine's role in addiction, and its use for treatment of smoking 7 and contributed to smoking being included as "tobacco dependence" and later "nicotine dependence" in the DSM. 8, 9 What is more recent is the emphasis on previously unknown neuromolecular pathways involved in nicotine addiction, [10] [11] [12] and the idea that addiction to nicotine can be treated by personalized pharmacotherapies targeting such pathways. 13 Because the "chronic relapsing brain disease" terminology, and its variations, are being used in clinical guidelines and the academic literature, it is important to investigate the meanings attached to such labels by smokers prior to their widespread dissemination. Previous research has shown that the application of biomedical labels and explanatory models can increase perceptions that a health condition is serious, 14 decrease perceptions of control over smoking, 15 increase recommendations for medical treatment, 15 and increase the stigma associated with mental illness. 16 This paper builds on this work by analyzing smokers' responses to the labelling of smoking as a "brain disease."
Method

Participants
The data presented in this paper are drawn from the qualitative component of a mixed methods project examining the implications of the brain disease model of addiction for smoking. 17, 18 The first author conducted semi-structured interviews with 29 daily smokers aged 18 years or older between October 2012 and July 2013. Interviews were audio recorded and transcribed verbatim. Participants were recruited from an Australian capital city via internet advertisements, community noticeboards, and hand-distributed flyers. Purposive sampling was used to maximize the diversity among participants in relation to age, gender, level of education, and heaviness of smoking. Of the 29 participants, 25 reported previously attempting to quit smoking. Seven participants reported no intention to quit smoking. Table 1 shows participant demographics. The Heaviness of Smoking Index (HSI) was calculated to measure nicotine dependence. 19 
Procedure
Participants first answered questions about their smoking, and viewed a brief presentation about how nicotine works in the brain to produce addiction adapted from a NIDA resource titled "Mind over matter: The brain's response to nicotine." 20 Participants' ideas and knowledge about the role of their brain in smoking are reported elsewhere. 17 Findings revealed that most participants were already aware that smoking works in the brain to produce addiction. While some participants had misgivings about explaining the brain's role in tobacco dependence, most accepted the role of the brain in smoking and thought that it was interesting and relevant information for smokers. 17 The data reported in the current paper is drawn from a subsequent question that specifically focuses on labelling smoking as a "brain disease." Thus, we are less interested here in participants' ideas about how their brain is involved in their smoking, but rather we focused on responses to scientists "labelling" smoking with the terminology of "brain disease." To elicit these reactions, the interviewer made the statement: "Based on the information presented earlier, some scientists have claimed that addiction is a brain disease." Respondents were asked what they thought about the idea that smoking was a brain disease, whether such a label would increase or decrease the stigma associated with smoking, and whether it was a good or bad way to describe smoking. Our aim was not to examine existing attitudes towards the idea that smoking is a brain disease, but to elicit smokers' initial reactions when presented with this controversial label.
KM analyzed the data using thematic analysis, according to the steps described by Braun and Clarke. 21 After close reading, initial codes which represented patterns observed within and across interviews were generated. These codes were combined into themes when they were deemed to represent a broader topic. AC independently coded and labelled themes from a subset of transcripts to ensure validity. Discrepancies were discussed until a consensus was reached about the final themes. Including a pattern as a theme was not determined by its prevalence within the dataset but according to its salience to the research question. 22 Qualitative research is a recursive process and during the analysis, we moved backwards and forwards between steps, for example amending labels for some codes once a broader understanding of the data had been obtained following the development of themes. Data were stored and managed using NVivo 10 software.
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Results
Interrogating the Perceived Accuracy of the "Brain Disease" Label of Smoking Many participants disagreed that cigarette smoking was a brain disease. Participants had diverse views of what the term "disease" meant. One referred to a disease as something that is "degenerative and harmful." (male, 26-40, moderate dependence). Another thought diseases were "viral" (male, 18-25, low dependence). Others associated the term with "brain damage" and rejected the idea that their brains were damaged, citing as evidence their participation as fully functioning members of society.
Some disliked the label but struggled to articulate why. They said it didn't "sound right," or that it was a "weird" label to apply to smokers. These participants reacted most strongly against the word "disease." The fact that nicotine may change the brain of smokers, however, was not disputed by most participants.
Yeah, I agree that, okay, I'm addicted to nicotine and, yeah, it affects my brain, I agree with all that, but no, I don't think, not as a disease, no. (female, 26-40, moderate dependence) Common beliefs that influenced participants' preparedness to accept or reject the idea that smoking was a brain disease included that a disease was something that an individual had no control over-it was something that "happened" to people. As one participant put it, a disease is "something that's caused by an outside influence." (female, 26-40, high dependence). This was seen as being inconsistent with smoking, which was conceptualized as an active choice made by an autonomous individual. The brain disease explanation was perceived as downplaying or ignoring the role of choice in smoking.
See, the thing is I could stop smoking right now. I could throw my ciggies in the bin and decide, no, never ever ever having one again. I mean, yeah, it's going to be a hard decision to make, but I can make it. I can do it. It's just I'm choosing not to. Anyone who disagrees is either an idiot or they're irresponsible (male, 26-40, low dependence)
In the quote above anyone who negates the importance of individual choice and Free will in smoking cessation is described as an "idiot" who is making "irresponsible" representations of smoking. This view was supported by the observation that people could quit smoking without assistance.
But then again, how is it then that some people can still stop if it's affecting-the heavy smokers-there have been heavy smokers that have stopped, so how is it that they've been able to do that if their brain-or is it like a lot of diseases, some people smoke, smoke, smoke and never get lung cancer, other people never smoke and get it. Yeah, it's probably a too general a hypothesis. (female, ≥55, high dependence) Some people thought that the term "disease" was too serious to apply to cigarette smoking. One participant thought that it would "make it look probably worse than what it is" (female, 18-25, low dependence). The role of nicotine addiction in sustaining smoking was downplayed by comparing smoking to other "habits":
It's something that your brain is accustomed to, just like how you're feeling-you know, like when you're driving how you check the mirrors, when you wake up how you do your hair, you brush your teeth. It's something that your brain picks up and learns. So what you can learn, you can unlearn. But I wouldn't go so far as to call it a disease. It's just harsh. (male, 18-25, low dependence)
A minority agreed that smoking was a brain disease. One reason for accepting this view was the invocation of a predisposition toward addiction in some individuals. For these participants, the fact that addiction ran in families, and individuals differed in their ability to quit, suggested that smoking was "more than a habit." Rather, it was a behavior with a physiological/genetic basis. These considerations made the brain disease concept more believable to them. Other participants thought that nicotine addiction might partially be understood as a brain disease, but the term was not seen as capturing the complexity of smoking in people's everyday lives:
Maybe partially, but I don't think fully. I don't think it's fully your brain. I think it's your daily life, your routine, your social group, it's everything else, I think, and then maybe partially a brain disease or whatever. It sounds really terrible saying it's a brain disease, but maybe partially. (female, 18-25, low dependence)
A handful of participants thought that the brain disease explanation may apply to some, but not all, smokers. For example, one participant stated that "normal" smoking would not be accurately classified as a brain disease, but once people were addicted enough to experience withdrawal symptoms, then this label might apply (female, 18-25, moderate dependence).
Concern About the Consequences of the "Brain Disease" Explanation of Smoking
While advocates of the brain disease model believe that it will reduce the stigma of addiction, most participants in this study thought that the brain disease label would increase the stigma of smoking. They attached negative connotations to the word "disease." Examples of words that participants associated with disease were: "dirty," "disability," "mental disorder," "leper," and "unstable." Associations with the concept of "brain damage" were seen as especially negative. One participant was concerned that he would become seen as the "local simpleton" if this terminology was introduced (male, 26-40, high dependence). Some participants were aware of the stigma and discrimination associated with mental illness, and were concerned that the brain disease label would equate smoking with a mental illness. Many reported feeling the stigma of smoking acutely, and reacted strongly to anything that they thought might increase this. …to what extent is brain condition conflated to mental illness and the assumptions are therefore maybe not being able to do their jobs or behave appropriately which mightn't actually be consciously examined assumptions but I think nevertheless we know they exist. (female, ≥55, moderate dependence)
Fewer participants thought that the brain disease explanation of addiction would reduce stigma. A minority thought it might reduce negative judgements of smokers because it implied they did not have full control over their behavior.
Yeah, there's always going to be a certain section of the community that goes, oh, those poor people, they've got a disease. I mean, yeah, but with education, we could reduce that. (male, 26-40, low dependence)
An associated apprehension was that other smokers would use the brain disease label to avoid personal responsibility for their smoking. It was often described as an "excuse" and a "cop out" that would discourage people from using their willpower to quit smoking.
No, I see it more as an excuse. They're going to go to their doctor and say I have a medical thing that I can't properly function anymore and I can't change it. Because a lot of people will say, no, it's deep in my brain, that's a serious problem as well, that's something that you might-I think it just opens a door to people who can't do the mind over matter or whatever. (male, 26-40, high dependence) Participants thought that "other" smokers would readily accept the implied reduction in personal responsibility but rarely saw their own smoking in this way. In contrast to the dominant view, just one participant reported that a biological understanding of smoking reduced her feelings of self-blame. She described the brain disease explanation as "comforting" because it provided a medical explanation for her struggle to control her cigarette intake (female, ≥55, moderate dependence). It was clear that the idea of having a brain disease was more likely to induce feelings of shame in smokers than to ameliorate them.
In relation to the implications of this terminology for treatmentseeking, participants differed in their views on the likely impacts of labelling smoking as a "brain disease." Some thought it may help smokers to recognize that they have a "real problem" thereby increasing treatment-seeking (female, 26-40, high dependence), or encouraging quitting because brains are "precious" organs associated with one's identity and spirituality. Others thought that a biomedical model would discourage quitting by making it seem more difficult.
It would make it look probably worse than what it is, and like I said before it might overwhelm a lot of people and they might think that there's nothing to do because they've got a disease, and I think disease is a big word. Probably for the medicine world it would be fine, but for the public, it's a big word to put in their minds. (female, 18-25, low dependence) A few male smokers expressed irritation at the thought of someone labelling them as having a brain disease, stating that they would be deterred from seeking treatment if health practitioners used this label for tobacco dependence.
I would be like-you think it's a disease, I'll show you disease, man. I'll smoke even more or something. (male, 18-25, low dependence) I just think it would scare smokers away from treatment programs. They're just saying-well my reaction would be look, just leave me alone please, stop talking, we've all got problems and throwing the word disease around is very dangerous, I think. (male, 18-25, low dependence)
These participants expressed suspicion about public health practitioners and scientists. Antismoking education campaigns were described as "scaremongering." One participant described them as "hippies," and another thought the brain disease label was a "nanny state" campaign to tell people that "we are not allowed to do what we want to do." (male, 41-54, high dependence). These participants thought that the brain disease definition was exaggerated or not entirely truthful, and asked to be presented with just "the facts." While few participants expressed such an explicit distrust of science, many disputed the "scientific claim" that addiction to smoking was a brain disease. Some were apologetic for disagreeing, or gave a disclaimer that they were not scientists and were simply expressing their personal opinion.
I wouldn't say it's a brain disease. I don't want to prove the scientists wrong, but it's just my opinion. I don't think it's a disease. (male, 26-40, low dependence)
It was common for participants to question the feasibility of introducing the brain disease label into public discourse about smoking. This was partly because they thought that it would not be accepted by most smokers, regardless of its scientific accuracy. One participant phrased this as "buy in." It was clear that many participants did not "buy into" the medical explanation of smoking as a brain disease. Some thought that this description of smoking was so inconsistent with existing conceptions of smoking that smokers would find it amusing to think of smoking in this way.
Discussion
While most participants accepted that nicotine acts on the brain to influence their smoking, the majority rejected the label of smoking as a brain disease. The main reasons for this were: doubts about the scientific accuracy of the claim; concerns that such terminology would increase stigma and prejudice against smokers; and a belief that it would lead smokers to absolve themselves of personal responsibility for their smoking. Participants believed that most smokers would reject the label, even if it was scientifically accurate.
While some participants deferred to the authority of science, accepting that smoking was a brain disease, most saw inaccuracies and deficiencies in the term. This is consistent with the empirical literature on public understanding of science, which shows that publics are not passive in their reception of scientific information; they more often resist or rework scientific ideas based on their own values or experiences. [24] [25] [26] [27] [28] While some participants apologized for disagreeing with scientists, a minority questioned the motives of public health practitioners. The latter group believed that they were being given biased information to manipulate their behavior. This highlights the importance of public trust in judgements about science and technology, which has long been recognized as an important influence on lay acceptance of scientific information. 28 The tobacco industry has fostered a distrust of public health by criticizing tobacco control strategies as "nanny state" interference in personal choice and "freedom." 29 They position smoking as a free choice made by responsible adults who can control their smoking through willpower. However, their opposition to plain packaging in Australia suggests they hold an alternative view of smokers as "manipulable with words, pictures, and colors." 30 A recent anthropological examination of smoking described two portrayals of smokers that both tobacco companies and public health employ. 30 The first is that smokers are "mindless consumers" who respond uncritically to tobacco industry persuasion and are "enslaved" by addiction. The second is that smokers are rational agents who make informed choices about smoking and respond to factual public health information and campaigns. Similarly, others 31 argue that the brain disease model has "remoralized" addiction.
Drug users are portrayed as "brain hostages" having lost control of their drug use, but at the same time are encouraged to take responsibility for protecting their brains and returning them to a healthy state. Constant vigilance is required to "avoid being terrorized by our own neural circuitry gone awry." 31 It was clear that our participants preferred to view themselves as rational subjects who could choose to stop smoking. 17 However, they often positioned other smokers as less informed, more addicted, and more likely to absolve themselves of personal responsibility by subscribing to a brain disease model of addiction. The gendered nature of beliefs about willpower and individual responsibility have been noted by others who have argued that the "masculine ideal" of an autonomous and self-contained individual, with internal resources of self-control and willpower, has been employed to minimize the tobacco industry's responsibility. 32 These views about the value of individual responsibility and inner strength persist strongly in societal discourses, although we found it was largely men who employed the "nanny state" discourse.
Suspicion of science and public health was not the most common reason for rejecting the brain disease label. As has been found in other qualitative research, personal experience is very influential. 33 Our participants drew on their own smoking careers, which often involved decades of smoking and many failed quit attempts, as well as observations of the smoking trajectories of their friends and family, to construct a schema of smoking. For many of them, the brain disease label was inconsistent with existing understandings of smoking. Many described smoking as a habit, or a matter of willpower. The idea of smoking as a choice, while co-opted by the tobacco industry, is also a part of public understandings of smoking because most smokers have observed people who have quit smoking and apparently succeeded without difficulty. 34, 35 The denial of choice and agency, as implied by the brain disease label, was a common reason participants gave for rejecting it.
Medicalization theorists have written that labelling a behavior as a disease is "to deem it undesirable." 36 Those interviewed reported experiencing significant smoking-related stigma in their everyday lives. They believed that the disease label was value-laden and had negative connotations that could increase stigma. This is consistent with research showing that the portrayal of mental illness as a disease or a biological phenomenon is more likely to increase the stigma directed towards people living with mental illness than reduce it. [37] [38] [39] [40] [41] These findings contrast with the claims by advocates of the brain disease model that describing addiction in this way will reduce the stigma that addicted individuals experience and lead to more humane policy responses. 1, 42 While some have argued that increasing stigma might increase quit attempts, 43 our research suggests the potential for stigma associated with medical labels to deter some smokers from seeing treatment. Most participants showed no interest in taking on a "sick role" in regards to their smoking. The potential for stigma may partly explain this, but also it may be because cigarettes have a "unique cultural location" in Western society. 44 Nicotine is acknowledged as addictive, however its use does not typically interfere with activities of everyday life. Also, the harms of smoking are perceived as "abstract possibilities"
44 when compared to the more immediate harms associated with addiction to most illicit drugs or alcohol. This makes intensive interventions such as drug rehabilitation or prescription medications for smoking cessation seem "too serious" for many smokers.
More so than reference to the brain, the word "disease" was problematic because smokers attached varied meanings to it. This is not surprising because the term lacks definitional clarity. [45] [46] [47] [48] This makes it easy to use narrow definitions of the term to dismiss it. Using the brain disease label may be counterproductive if potentially useful (and more acceptable) messages about the brain's role in smoking are disregarded. Because the term "brain disease" could create confusion, distrust, and disbelief among smokers, it may not be helpful in health promotion material or clinical interactions. However, rejection of the "brain disease" label does not rule out a more nuanced view of the brain's role in smoking. This could play a useful role in providing smokers with insight into their smoking. In fact, many participants who rejected the brain disease label found information about the brain's role brain in smoking interesting and thought it provided insights into their smoking. 17 It must be noted that this was exploratory qualitative research, and research with other populations and larger samples is warranted to further explore these possibilities. Quantitative research on this topic would allow for investigation of possible demographic differences, for example, in relation to age, gender, or education. Given the negative reactions of participants to the word "disease" further research could also investigate whether alternative terminology, such as smoking being a "brain disorder" or a "brain condition" is more likely to be accepted by smokers.
Some may argue that smoking is not often described as a brain disease in current smoking cessation literature. However, the use of this type of language is implicit in the rationale offered for medical approaches to smoking cessation, for example, drug treatments such as varenicline that act on neurotransmitters, and novel experimental treatments such as transcranial magnetic stimulation that act on brain function. 49 This conceptualization of addiction is also promoted in health education materials disseminated by NIDA that are designed for use by the general public and schools. 2, 20 Moreover, the results reported here demonstrate that it is the label of smoking as a "chronic disease" that many people rejected, rather than the emphasis on the brain, and multiple authors have called for tobacco dependence to be treated as a chronic disease, similar to diabetes or hypertension. 4, 5, 50, 51 The results of this research show that medicalized definitions may be at odds with the way that smokers understand their own smoking. In general, our participants felt that the brain disease terminology did not capture the complexity of their smoking, that it could increase stigma, and that it may diminish perceptions of autonomy and choice in smoking cessation, something that was believed to be key to a successful quit attempt. Because we have previously shown that the same participants generally agreed that smoking contributes to addiction by altering neurochemistry, 17 we conclude that it is the "labelling" of smoking as a "chronic disease" or a "brain disease" that may increase some smokers' distrust of health professionals, deterring them from seeking assistance to quit. The fact that the brain disease label was discordant with the lived experience of smokers should be thoughtfully considered in debates about the social benefits of this approach to addiction. More nuanced accounts of the brain's role in addiction are likely to be more acceptable to smokers and alternative terminology should be investigated. 
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